Available IPD datapackage for study 'A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma'

Name: Available IPD datapackage for study 'A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma'
Creator: Vivli
Published: 2025-07-07 15:13:20
License: 暂无描述

DataCite Commons2025-07-07 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00005068.1

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to test whether SU011248 has activity and is safe compared to interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (RCC).

提供机构：

Vivli

创建时间：

2025-07-07